Esperion ETC 1002 Study Nov 1, 2016 - Mar 31, 2019

PIONEER5: Efficacy and safety of oral semaglutide versus placebo in subjects with type 2 diabetes and moderate renal impairment Nov 1, 2016 - Oct 31, 2019
Clinical trial of an investigational medicinal product

NHS Contract reference R1999

TRANSFORM: Reducing Inequalities in Cancer Outcomes in Yorkshire: Realising our potential for innovation in Diagnosis, Patient Management, Survivorship and Palliative Care Research Sep 1, 2017 - Aug 30, 2024
The death rate is higher in Yorkshire than the rest of England resulting in about 200 extra deaths each year of which more than half are in Hull. There are other significant cancer outcome inequalities between different groups; for example poorer pe... Read More

PEOPLE: Primary care and community Engagement to Optimise time to Presentation with Lung cancEr symptoms in HULL Jun 1, 2017 - Aug 30, 2022
More people are diagnosed with and die from lung cancer in Hull than any other place in Yorkshire. Our aim is to improve earlier diagnosis of lung cancer by [1] getting people to see their doctor if they get lung symptoms and [2] getting GPs to refe... Read More

A Double-blind, Randomized, Parallel-group, Placebo-controlled Study of MLE4901 for the Treatment of Polycystic Ovary Syndrome (PCOS) Jan 11, 2017 - Jan 10, 2018

Does glycated hemoglobin variability in type 2 diabetes differ depending on the diabetes treatment used in the Qatari population: implication on diabetes complication risk Aug 1, 2016 - Jul 31, 2020

FRAIL-HEART: Assessment of Frailty in Elderly People with Ischemic Heart Disease being considered for Revascularisation: An Observational study Apr 1, 2017 - Mar 31, 2020

BREATHE: Breathlessness RElief AT HomE Apr 1, 2019 - Oct 31, 2021
A feasibility study to address this RQ:
Does a paramedic-administered short non-pharmacological complex breathlessness intervention improve breathlessness and reduce conveyance to ED for people with breathlessness crisis compared with usual pr... Read More

Liberates: Improving glucose control in patients with diabetes following myocardial infarction: The role of a novel glycaemic monitoring strategy Aug 1, 2017 - Jul 31, 2020

IVF Study 1: Does Insulin or Endocrine Disruptor levels affect fertility? Jan 1, 2014 - Dec 31, 2018
£50067 of Keith's salary to come from Hull IVF Trust as well as all consumables and the remainder of Keith's salary is to cme from an existing FSA award._x000D_
 

IVF Study 2: Does Insulin or Endocrine Disruptor levels affect fertility? Jan 1, 2014 - Dec 31, 2018
other half of pfact 6134 - HULL IVF Trust

Trial net CRN funding Jan 1, 2016 - Dec 31, 2018
CRN funding to cover Dawn Lowsley from 01/01/2015 for 1 day a week for 2 years to assist with trial recruitment

Empress: NAEDI Cancer diagnosis via emergency presentation: a case control study (colorectal and lung cancer) Oct 1, 2015 - Sep 30, 2020

On encountering corpses: political, socio-economic and clutural aspects of contemporary encounters with dead bodies. Oct 1, 2014 - Feb 28, 2018

The MID (Multi-Modal Intervention Diabetes) - Frail Study Jun 1, 2015 - Apr 30, 2018
Hi Katherine Dr Sathyapalan will be conducting the above study, please note that this study is not commercial study. However, it's funded by EU and Sathya would like to put this through University. James Illingworth has checked through the contract a... Read More

Soy and testosterone: T01057 - Double placebo controlled parallel trial of soy phytoestrogens in patients with compensated hypogonadism Oct 1, 2009 - Apr 30, 2019

TSB Costs (Study 1, 2, 3 & 4): In vitro and in vivo assessment of polyphenol extracts on cardiovascular indices Jan 1, 2012 - Aug 1, 2016
Evidence suggests dietary plant polyphenols are associated with reducing indices of cardiovascular disease such as endothelial dysfunction, insulin resistance and hypertension. The key objectives of this translational research proposal are to study a... Read More

ISCHEMIA: Internation Study of Comparative Health Effectiveness with Medical and Invasive Approaches Apr 15, 2013 - Jun 30, 2019
Primary objective is to determine whether an invasive (INV) strategy of routine early cardiac catheterization with intent for optimal revascularization in addition to optimal medical therapy in patients with stable ischemic heart disease (SIHD) and a... Read More

Sandoz Ltd unfettered donation May 1, 2013 - Dec 31, 2017

Albiglutide + Insulin Glargine Versus Insulin Lispro + Insulin Glargine in the Treatment of Subjects with Type 2 Diabetes Mellitus: The switch Study Jun 1, 2015 - Aug 1, 2018